Tuesday, November 07, 2017 10:24:02 PM
In the 5 years this management team has been here, they have invested in and improved their product offerings, and repositioned them to be more client focused. This has been a very good business strategy and they have earned an excellent reputation, developed long-standing relationships with all of the top names in the cell therapy and pharma industry, and now have established a commanding leadership position and a very long list of loyal clients. This year revenues have increased over 50%, they have reduced expenses, increased margins, transitioned outsourced sales and marketing staff in-house, prepared for at least 2 commercial launches, and hired executives to focus on landing large pharma and consulting contracts. And yes, they have landed 68 new biopharma accounts, netted 66 new clinical trials, and signed the first 2 commercial CAR-T contracts this year. How’s that for “executing a successful business plan?”
Yes, there are some here who are complaining that management is not providing enough information during the conference calls to maintain the stock price It’s a legitimate complaint, but that’s not really management’s job is it? I think in general, some analysts like to be spoon fed earnings estimates from the company rather than doing some of the work themselves. But in this case, it’s difficult to project earning for Cryoport right now because they are still at the developmental stage and transitioning into a commercial stage company and earnings can be unstable and analysts are a little more dependent upon guidance from management. Almost 75% of their revenues are from clinical trials which can vary widely, and management hasn’t given the exact figures to be able to accurately calculate expected revenues from these trials. In addition, management has been rather tight lipped about some of the critical aspects of the recent commercial contracts they have signed. The timing and amount of expected revenues will help analysts accurately project revenues in the following quarters and years and write reports and advise their clients to purchase the stock which supports the price. The problem is that Cryoport supports a number of very large clients who are competing directly with each other and therefore cannot disclose all the information that analysts and investors would probably like.
In my opinion, Cryoport’s management is decent, and is not the reason the stock price has fallen. If management concentrates on running the company, and “executing a successful business plan” as you say, the stock price will take care of itself. I’m very confident your investment is safe and the stock price will make new highs again.
The board is certainly better with more information shared from many people with different backgrounds, expertise, and experiences and I look forward to your contributions.
Recent CYRX News
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/03/2024 08:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 11:11:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:28:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 06:55:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/07/2024 12:00:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 09:17:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:34:57 PM
- Cryoport Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/06/2024 08:15:00 PM
- Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes • PR Newswire (US) • 08/06/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/02/2024 08:22:37 PM
- Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024 • PR Newswire (US) • 07/23/2024 12:30:00 PM
- Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies • PR Newswire (US) • 06/20/2024 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/14/2024 08:31:02 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2024 08:45:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 09:10:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:03:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:01:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 11:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 11:28:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:53:55 PM
- Cryoport Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/07/2024 08:08:00 PM
- Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024 • PR Newswire (US) • 04/30/2024 12:30:00 PM
- Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/12/2024 08:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 • PR Newswire (US) • 02/27/2024 01:30:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM